Ivey Business School (Canada)
-
Change at Pfizer: Jeff Kindler (C) Post Wyeth Acquisition Organization
Michael J. Rouse; Chander SehgalCase IVEY-9B10M054-EStrategyThis case is a supplement to Change at Pfizer: Jeff Kindler (A).Starting at €5.74
-
Extraordinary Journeys: Wild Times in the Safari Industry (Spanish version)
David HallidayCase IVEY-W28187Entrepreneurship, StrategyIn April 2017, an entrepreneur in the tour operator industry faced a potential investment decision. Her company, Extraordinary Journeys (EJ), created custom luxury African safaris for a US-based clientele. While EJ had enjoyed dramatic growth since its founding in 2009, the entrepreneur worried that competitive pressures were increasing, as resource-rich companies had entered the market, drawn by the industry's rapid growth. In response to this g...Starting at €8.20
-
Strategizing at Monarchia Matt International (MMI)
Michael J. Rouse; Jordan MitchellCase IVEY-9B07M014-EEntrepreneurship, StrategyAs of late 2004, the chief executive officer (CEO) of New York-based wine distributor Monarchia Matt International (MMI) is looking at his portfolio of wines and wondering what advantage Hungarian wine could provide in becoming a powerful niche player in the highly fragmented and complicated U.S. wine industry. The CEO is cognizant of Hungarian wine's reputation in the United States as an inexpensive, mass-quantity produced and low quality drink....Starting at €8.20
-
Extraordinary Journeys: An Acquisition Expedition
David HallidayCase IVEY-9B21M008-EStrategyIn late 2015, the chief executive officer of Extraordinary Journeys, an African safari tour operator, faced a rare opportunity to buy a smaller competitor, Safari Specialists Inc. The chief executive officer worried that her firm's strong organic growth would slow, and she was interested in examining alternative growth strategies. The smaller company was offered at a reasonable price and had a remarkably similar organizational culture. On the oth...Starting at €8.20
-
Change at Pfizer: Jeff Kindler (A)
Michael J. Rouse; Chander SehgalCase IVEY-9B10M014-EStrategyPfizer Inc., the largest research-based drug company in the world, was faced with multiple challenges, including fierce court battles with generic drug companies over the patents of Lipitor, reduced productivity from research and development, and a changing external health care environment globally, with growing importance of emerging markets. These challenges were set within a business environment characterized by multi-level change and uncertai...Starting at €8.20
-
Change at Pfizer: Jeff Kindler (B) The Wyeth Acquisition
Michael J. Rouse; Chander SehgalCase IVEY-9B10M053-EStrategyThis supplement to Change at Pfizer: Jeff Kindler (A) deals with Pfizer’s 2009 acquisition of Wyeth — the first mega-acquisition since the world economic crisis.Starting at €5.74
-
Extraordinary Journeys: Wild Times in the Safari Industry
David HallidayCase IVEY-9B18M164-EEntrepreneurship, StrategyIn April 2017, an entrepreneur in the tour operator industry faced a potential investment decision. Her company, Extraordinary Journeys (EJ), created custom luxury African safaris for a US-based clientele. While EJ had enjoyed dramatic growth since its founding in 2009, the entrepreneur worried that competitive pressures were increasing, as resource-rich companies had entered the market, drawn by the industry's rapid growth. In response to this g...Starting at €8.20